Excellergy
Developer of protein therapeutics designed to combat severe allergic diseases. The company offers specialized expertise in IgE biology and anti-IgE molecular pharmacology, enabling patients with sever...
Valuation
$122.2M
Market implied
Share Price
N/A
Total Raised
$79.8M
Last Round
N/A